Notable Labs, Ltd.
NTBLQ
$0.00
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 3,812.50% | 3,787.50% | 3,775.00% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3,812.50% | 3,787.50% | 3,775.00% | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1,350.00% | 1,325.00% | 1,312.50% | -- | -- |
| SG&A Expenses | 19.64% | 15.57% | 95.15% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.19% | -5.59% | 15.73% | -- | -- |
| Operating Income | -15.90% | 7.74% | -13.40% | -- | -- |
| Income Before Tax | 39.83% | 50.10% | 21.82% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 39.83% | 50.10% | 21.82% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.83% | 50.10% | 21.82% | -- | -- |
| EBIT | -15.90% | 7.74% | -13.40% | -- | -- |
| EBITDA | -16.42% | 7.55% | -14.27% | -- | -- |
| EPS Basic | 87.87% | 43.70% | -521.07% | -- | -- |
| Normalized Basic EPS | 87.87% | 43.70% | -459.33% | -- | -- |
| EPS Diluted | 87.87% | 43.70% | -521.07% | -- | -- |
| Normalized Diluted EPS | 87.87% | 43.70% | -459.33% | -- | -- |
| Average Basic Shares Outstanding | 30.90% | -8.36% | -37.58% | -- | -- |
| Average Diluted Shares Outstanding | 30.90% | -8.36% | -37.58% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |